`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`Petitioner
`
`v.
`
`ALLERGAN, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2017-00583
`Patent 8,633,162
`
`
`
`
`
`
`
`PATENT OWNER ALLERGAN, INC.’S
`MANDATORY NOTICES
`
`
`
`Case IPR2017-00583
`Attorney Docket No: 13351-0008IPJ
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, Allergan, Inc. (“Patent
`
`Owner”), hereby submits the following Mandatory Notices in response to the
`
`Petition for Inter Partes Review of U.S. Patent No. 8,633,162.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`Allergan, Inc. is the Patent Owner and the Real Party-In-Interest in this
`
`proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding: Allergan, Inc. v. Teva Pharmaceuticals USA, Inc., et
`
`al., No. 2:15-cv-01455 (D. Texas); Allergan, Inc., v. Innopharma, Inc. and Pfizer,
`
`Inc., No. 2:15-cv-1504 (D. Texas); and Allergan, Inc. v. Famy Care, Ltd., No.
`
`2:16-cv-0401 (D. Texas).
`
`The following petitions for inter partes review are related to U.S. Patent No.
`
`8,633,162: IPR2015-01278 (terminated before institution), U.S. Patent Nos.
`
`8,648,048 (IPR2015-01284, terminated before institution), 8,642,556 (IPR2015-
`
`01286, terminated before institution), 8,629,111 (IPR2016-01232 and IPR2015-
`
`01282, terminated before institution), and 8,685,930 (IPR2015-01283, terminated
`
`before institution).
`
`2
`
`
`
`Case IPR2017-00583
`Attorney Docket No: 13351-0008IPJ
`The following petitions for inter partes review are pending for U.S. Patent
`
`No. 8,633,162 (IPR2016-01130 IPR2017-00568, IPR2017-00599), and related
`
`U.S. Patent Nos. 8,685,930 (IPR2016-01127, IPR2017-00571, IPR2017-00594,
`
`IPR2017-00576), 8,629,111 (IPR2016-01128, IPR2017-00567, IPR2017-00596,
`
`IPR2017-00578), 8,642,556 (IPR2016-01129 IPR2017-00570, IPR2017-00598,
`
`IPR2017-00579), 8,648,048 (IPR2016-01131, IPR2017-00566, IPR2017-00600,
`
`IPR2017-00585), and 9,248,191 (IPR2016-01132, IPR2017-00569, IPR2017-
`
`00601, IPR2017-00586).
`
`The following patents and pending patent applications are related to U.S.
`
`Patent No. 8,633,162: U.S. Application No. 15/011,159, filed January 29, 2016,
`
`claims the benefit of U.S. Application No. 14/222,478 (9,248,191), which is a
`
`continuation, via U.S. Application Nos. 13/961,828 and 11/897,177, of U.S.
`
`Application No. 10/927,857.
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`BACK-UP COUNSEL
`Michael Kane, Reg. No. 39,722
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2502
`Email: PTABInbound@fr.com
`Fax:
` (612) 288-9696
`
`LEAD COUNSEL
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email: IPR13351-0008IPJ@fr.com
`Fax: (612) 288-9696
`
`
`
`3
`
`
`
`Case IPR2017-00583
`Attorney Docket No: 13351-0008IPJ
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`4.
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email at IPR13351-0008IPJ@fr.com
`
`(ref.: Docket No. IPR13351-0008IPJ).
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`
`
`4
`
`
`
`
`
`Date/January 23, 2017/
`
`
`Customer Number 26191
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`
`
`Case IPR2017-00583
`Attorney Docket No: 13351-0008IPJ
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on January 23, 2017, a complete and entire copy of this Patent Owner
`
`Allergan, Inc.’s Mandatory Notices and Power of Attorney were provided via
`
`electronic service, to the Petitioner by serving the correspondence address of
`
`record as follows:
`
`Gary J. Speier
`Mark D. Schuman
`Carlson, Caspers, Vandenburgh, Lindquist & Schuman, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, Minnesota 55402
`
`gspeier@carlsoncaspers.com
`mschuman@carlsoncaspers.com
`IPRCyclosporine@carlsoncaspers.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Jessica K. Detko/
`
`Jessica K. Detko
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(612) 337-2516
`
`
`
`
`
`
`
`
`
`
`
`
`